5 | Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2015
-
07/2004 |
4 | Busulfan (Busulfex)FDA Link
09/2017
-
07/2004 |
3 | fludarabineIBA
09/2017
-
07/2004 |
3 | Lenalidomide (CC 5013)FDA Link
04/2016
-
02/2010 |
3 | HLA Antigens (Human Leukocyte Antigens)IBA
09/2015
-
11/2010 |
2 | Chimeric Antigen ReceptorsIBA
05/2024
-
01/2022 |
2 | SteroidsIBA
10/2017
-
10/2012 |
2 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2016
-
12/2015 |
2 | Rituximab (Mabthera)FDA Link
09/2016
-
10/2012 |
2 | Interleukin-22 (IL-22)IBA
03/2016
-
07/2013 |
2 | Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2015
-
09/2004 |
2 | Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2015
-
09/2004 |
2 | Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2014
-
04/2005 |
2 | Thalidomide (Thalomid)FDA Link
02/2005
-
01/2005 |
1 | fenixIBA
05/2024 |
1 | bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
05/2024 |
1 | idecabtagene vicleucelIBA
05/2024 |
1 | B-Cell Maturation AntigenIBA
05/2024 |
1 | Immunosuppressive Agents (Immunosuppressants)IBA
11/2021 |
1 | HLA-A Antigens (HLA-A)IBA
01/2021 |
1 | HLA-DQB1 antigen (HLA DQB1)IBA
01/2021 |
1 | C-Reactive ProteinIBA
10/2017 |
1 | Gemtuzumab (Mylotarg)FDA Link
04/2017 |
1 | Sorafenib (BAY 43-9006)FDA Link
03/2017 |
1 | Janus Kinase InhibitorsIBA
02/2017 |
1 | Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
02/2017 |
1 | elotuzumabIBA
01/2017 |
1 | Monoclonal AntibodiesIBA
01/2017 |
1 | PanobinostatIBA
01/2017 |
1 | daratumumabIBA
01/2017 |
1 | pomalidomideIBA
01/2017 |
1 | ixazomibIBA
01/2017 |
1 | carfilzomibIBA
01/2017 |
1 | Brentuximab VedotinIBA
10/2016 |
1 | ErbB Receptors (EGF Receptor)IBA
04/2016 |
1 | gallium 68 PSMA-11IBA
04/2016 |
1 | 23-seleno-25-homotaurocholic acidIBA
04/2016 |
1 | Dictyostelium severin protein (severin)IBA
04/2016 |
1 | lipoarabinomannan (LAM)IBA
04/2016 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2016 |
1 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
04/2016 |
1 | melanin-concentrating hormone receptorIBA
04/2016 |
1 | multidrug resistance-associated protein 1IBA
04/2016 |
1 | fluorocholineIBA
04/2016 |
1 | fluoromethylcholineIBA
04/2016 |
1 | 5-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA
04/2016 |
1 | radium Ra 223 dichlorideIBA
04/2016 |
1 | Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2016 |
1 | AcidsIBA
04/2016 |
1 | AerosolsIBA
04/2016 |
1 | Carbon MonoxideIBA
04/2016 |
1 | Choline (Choline Chloride)IBA
04/2016 |
1 | Ciprofloxacin (Cipro)FDA LinkGeneric
04/2016 |
1 | Dihydroxyphenylalanine (Dopa)IBA
04/2016 |